India’s first National IPR Policy maintains position on affordable drugs

May 31 2016

The India government has unveiled the first National Intellectual Property Rights Policy that sets out seven objectives and relevant guidelines to promote the country’s IP regime, and has resisted pressure from the United States to amend the patent law regarding access to cheap drugs

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

more from across site and SHARED ros bottom lb

More from across our site

Trademarks

Podcast special: Ringside with Brandsmiths and Bird & Bird

IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications

Max Walters, July 09 2025

Trademarks

‘Women must focus on owning equity’: Abion CEO on leadership

Magdalena Bonde discusses Abion’s AI experiments and reveals why an entrepreneurial mindset and a willingness to learn about a business are essential skills

Sukanya Sarkar, July 09 2025

Trademarks

Behind the case: DLA Piper pops corks after Champagne TM win

Partner Ginevra Righini explains how she secured victory for the Comité Champagne in its fight against an EUTM application for ‘Nero Champagne’

July 07 2025

Patents

IP firm founder on Hamlet, yoga, and the power of patents

Volkan Hamamcıoğlu joins us for our ‘Five minutes with’ series to discuss meditation, tackling deadlines, and taking inspiration from Hamlet

July 07 2025

Patents

This week on MIP: Tesla’s UK comeback | EBoA clarifies prior art standard

A $110 million US verdict against Apple and an appellate order staying a $39 million trademark infringement finding against Amazon were also among the top talking points

Sukanya Sarkar, July 04 2025

Trademarks